FP

Flagship Pioneering Portfolio holdings

AUM $268M
This Quarter Return
-20.21%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$2.65B
AUM Growth
+$2.65B
Cap. Flow
-$645M
Cap. Flow %
-24.3%
Top 10 Hldgs %
99.61%
Holding
13
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

1
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
$57.8M

Top Sells

1
MRNA icon
Moderna
MRNA
$671M
2
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
$32.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNA icon
1
Moderna
MRNA
$9.37B
$1.84B 69.35% 12,886,743 -4,694,273 -27% -$671M
SANA icon
2
Sana Biotechnology
SANA
$777M
$220M 8.29% 34,239,018 – –
FHTX icon
3
Foghorn Therapeutics
FHTX
$286M
$172M 6.49% 12,674,120 – –
EVLO
4
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$106M 4.01% 50,427,328 +27,397,259 +119% +$57.8M
OMGA
5
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$98.4M 3.71% 25,902,269 – –
DNLI icon
6
Denali Therapeutics
DNLI
$2.23B
$77.1M 2.9% 2,619,968 – –
MCRB icon
7
Seres Therapeutics
MCRB
$166M
$49.3M 1.86% 14,378,802 – –
AXLA
8
DELISTED
Axcella Health Inc. Common Stock
AXLA
$38.3M 1.44% 18,867,785 – –
RUBY
9
DELISTED
Rubius Therapeutics, Inc
RUBY
$32.7M 1.23% 38,506,526 – –
SGTX
10
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$8.61M 0.32% 10,370,369 – –
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$7.51M 0.28% 2,607,303 – –
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.82M 0.11% 2,938,494 – –
KLDO
13
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
– – -19,575,710 Closed -$32.3M